Medicare (temporarily) covers GLP-1s starting tomorrow
Key takeaways
- Link copied by Joseph Choi and Nathaniel Weixel - 06/30/26 6:49 PM ET Link copied NOW PLAYING Click in for more news from The Hill{beacon}
- The Trump administration s temporary program to cover GLP-1 medications for obesity starts tomorrow and runs through 2027, but we still don t know for sure how much it will cost taxpayers.
- Medicare is prohibited by law from covering weight-loss drugs but the Centers for Medicare and Medicaid Services is allowed to test new payment models under short-term pilot programs.
Why this matters: political developments that affect policy direction and public trust.
Link copied by Joseph Choi and Nathaniel Weixel - 06/30/26 6:49 PM ET Link copied NOW PLAYING Click in for more news from The Hill{beacon}
The Trump administration s temporary program to cover GLP-1 medications for obesity starts tomorrow and runs through 2027, but we still don t know for sure how much it will cost taxpayers.
Medicare is prohibited by law from covering weight-loss drugs but the Centers for Medicare and Medicaid Services is allowed to test new payment models under short-term pilot programs. Eli Lilly and Novo Nordisk agreed to a monthly $245 price for their respective GLP-1 drugs, and in exchange will have access to a new pool of eligible Medicare beneficiaries.